SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-010036
Filing Date
2023-06-20
Accepted
2023-06-20 16:10:09
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 form4-06202023_080604.html 4  
1 form4-06202023_080604.xml 4 4036
  Complete submission text file 0001415889-23-010036.txt   5610
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 555 CALIFORNIA STREET SUITE 365 SAN FRANCISCO CA 94104
Business Address
NEIL GARRY ARTHUR (Reporting) CIK: 0001586785 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 231025124